comparemela.com

Latest Breaking News On - Standard of the frankfurt stock exchange - Page 17 : comparemela.com

3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24

EQS-News: BRAIN Biotech AG / Key word(s): Quarterly / Interim Statement3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 28.02.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.3M FY 23/24:  BRAIN Biotech looks optimistic to.

3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 -February 28, 2024 at 01:32 am EST

EQS-News: BRAIN Biotech AG / Key word: Quarterly / Interim Statement 3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24.

EQS-Adhoc: Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE - adhoc - Börsennachrichten

EQSAdhoc Kontron AG Key word Mergers & Acquisitions Adhoc Kontron AG LinzAustria Closing conditions met for the acquisition of around 59% of the shares in KATEK SE 28Feb2024 1200 CETCEST Disclosu

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.